曾 櫻枝

Medicine & Life Sciences

1. Parkinson Disease 100%
2. Gait 97%
3. Sleep 85%
4. Cognitive Dysfunction 71%
5. Sleep Stages 53%
6. Type A Botulinum Toxins 48%
7. Triple Negative Breast Neoplasms 48%
8. Nitric Oxide Synthase Type II 41%
9. Paclitaxel 40%
10. Breast Neoplasms 40%
11. Aziridines 39%
12. Sulfanilamides 39%
13. Hemophilia A 39%
14. Cell Line 37%
15. Short-Term Memory 37%
16. Muscles 35%
17. Anhydrides 30%
18. Exercise 30%
19. Disability Evaluation 29%
20. Walking 29%
21. Levodopa 28%
22. Randomized Controlled Trials 28%
23. Public Health Nurses 28%
24. recombinant FVIIa 27%
25. Diabetic Neuropathies 27%
26. Hemothorax 26%
27. Cantharidin 26%
28. Circadian Rhythm 26%
29. Compression Fractures 25%
30. Methylenetetrahydrofolate Reductase (NADPH2) 25%
31. Memory Consolidation 25%
32. Arm 24%
33. Efficiency 24%
34. Continuing Education 24%
35. Pain Perception 23%
36. Botulinum Toxins 23%
37. Dementia 23%
38. Osteoporotic Fractures 23%
39. Pelvic Floor 23%
40. Accidental Falls 23%
41. Neuralgia 23%
42. Positive-Pressure Respiration 23%
43. Intracranial Hemorrhages 22%
44. Music 22%
45. A549 Cells 22%
46. Carcinoma 21%
47. Cancer Survivors 21%
48. Urinary Incontinence 21%
49. Homocysteine 21%
50. REM Sleep 21%